Warren, Fischer Applaud Unanimous Passage of Bipartisan Resolution Designating September 2026 as Polycystic Ovary Syndrome Awareness Month

PCOS is a complex hormonal, metabolic, and reproductive disorder that researchers estimate affects 10% of women in the United States and is a leading cause of infertility. Text of Resolution (PDF) Washington, DC – Today, United States Senators Elizabeth Warren (D-Mass.) and Deb Fischer (R-Neb.) applauded the unanimous passage of their bipartisan resolution recognizing the seriousness of Polycystic Ovary Syndrome (PCOS) and expressing their support for the designation of September as PCOS Awareness Month. The senators reintroduced the resolution on September 30, 2026, and it was formally adopted by the Senate on the same day. “One in ten women in the United States are affected by PCOS, but many don’t even know they have it. That’s why raising public awareness of PCOS is critical to supporting those affected,” said Senator Warren . “We must keep pushing for more research, better and more personalized treatments, and a cure.” “Polycystic Ovary Syndrome affects millions of women and is the leading cause of infertility,” said Senator Fischer . “This resolution will raise awareness while underscoring the need for more research and accessible treatment. I thank Senator Warren for her partnership as we continue working to support women and families.” PCOS is a complex hormonal, metabolic, and reproductive disorder that affects ten percent of women in the United States. PCOS is the most common endocrine disorder among women and is a leading cause of infertility. People with PCOS also often suffer from psychosocial disorders, such as anxiety, depression, and eating disorders, and have a higher risk of developing diabetes, cardiovascular disease, and fatty liver disease. Some studies have shown that suicide attempts are up to 7 times more common in people with PCOS due to the disorder’s anxiety and depression symptoms. There is currently no cure for PCOS, and 70 percent of women living with the syndrome are undiagnosed. In 2026, polyendocrine metabolic ovarian syndrome (PMOS) was selected as the new name for polycystic ovary syndrome (PCOS) through an international multistakeholder process that provides for both terms to remain in use during a multiyear transition. The resolution highlights the symptoms and prevalence of PCOS and expresses the support of the Senate for increasing awareness of the disorder, improving PCOS diagnosis and treatment, and improving the quality of life of people living with PCOS. The resolution also recognizes the need for further research on PCOS and urges medical researchers and health care professionals to advance their understanding of the disorder. Senator Warren and then-Senator David Perdue (R-Ga.) first introduced this bipartisan resolution in November 2017. ###